FT Pharma Pricing and Value Summit
The pharmaceutical pricing and market access landscape is being transformed by a host of factors. Value-based pricing is making the transition from concept to reality, but more clarity is needed on what it means and how it works for different stakeholders. Revolutionary therapies with innovative pricing models are entering the market but at the same time decision-makers at pharma companies are being asked to defend pricing strategies for established products. Meanwhile, much of the US government's blueprint to lower drug prices is still in the works and yet to be enacted.
As founding partners of the FT Pharma Pricing and Value Summit, Huron Life Sciences look forward to sponsoring the speaker’s dinner, hosting the VIP breakfast and speaking on the main program on “New Business Models to Support Innovation in Payer”.
- Chris Easley
- Contact Me